You have been chosen to receive this valuable information.
 
A SPECIAL
ANNOUNCEMENT FROM:
   PE Logo  
 
 
Plus, honorary chairs, keynote speaker, program highlights, and more!
Add Americas@DIAglobal.org.
 
 
DIA 2018
The DIA 2018 Global Annual Meeting will host thousands of professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries around the globe and 450+ exhibiting companies. As largest, longest-running event in the life sciences industry, this gathering is designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies.

Honorary Chairs Announced!
 
spacer Julie Louise Gerberding, MD, MPh
Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health
Merck & Co., Inc.
 
spacer Tatsuya Kondo, PhD, MD
Chief Executive
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
 
Keynote Speaker Announced!
 
spacer Nora D. Volkow, MD
Director
National Institute on Drug Abuse (NIDA), NIH
 
View All Speakers
The program is packed with more than 200 sessions across 12 educational tracks, offering new learning formats to diversify and customize your experience, matching your preferred learning style with content that fulfills your interests to create the perfect meeting for you.

 
Download Preliminary Program
8 Reasons to Attend
 
  Featured Sessions in Regulatory
 
 
  Lf Border   Analyzing Innovation's Progress in the Gottlieb Era  
 
 
 
  Lf Border   EMA/FDA Question Time  
 
 
 
  Lf Border Using Real World Evidence for Regulatory Support: Time to Embrace the Future  
 
 
 
  Lf Border Artificial Intelligence: The Future of Regulatory Affairs  
 
 
 
  Lf Border What Can We Say About Combination Products: Labeling, Advertising, and Promotion of Combination Products  
 
 
 
  Lf Border AdPromo: Assessing Risk in the Current Regulatory Environment  
 
 
 
  Lf Border Update on BREXIT  
 
 
View All Regulatory Sessions
 
 
  Featured Sessions in Clinical Safety and Pharmacovigilance
 
 
  Lf Border   Triple-A RWE: Adequate Data, Appropriate Study Designs, and Actionable Evidence  
 
 
 
  Lf Border Payers, Industry, and Academia Collaborating on Post-Marketing Surveillance  
 
 
 
  Lf Border Pharmacovigilance: No Longer Going it Alone  
 
 
 
  Lf Border Reducing the Burden of Drug Safety Risk Minimization Programs on the Healthcare System: How Do We Do So and What has Been Learned to Date?  
 
 
 
  Lf Border Automation in Pharmacovigilance: Doing More with Less  
 
 
 
  Lf Border Risk Communication and Patient Safety: Recent Learnings and New Approaches  
 
 
View All Safety Sessions
 
Need more reasons to attend?

Get an inside look at what's in store for this year's event. Session rooms overflowed daily at DIA 2017 as panelists convened for open conversations on the hottest topics in healthcare product development and patient care. Download our exclusive report on reflections and highlights from the meeting in Chicago, plus video recordings of all 11 DIAmond sessions!

Access DIAmonds
 
 
 
facebook   linkedin   Twitter   instagram   youtube
 
DIA
800 Enterprise Road, Suite 200
Horsham, Pennsylvania 19044-3595
T. +1.215.442.6100 or toll-free at +1.888.257.6457
F. +1.215.442.6199
E. Americas@DIAglobal.org
                                                           
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Executive, a UBM publication. You are on the mailing list as %%emailaddress%%.